OOIR: Observatory of International Research

Papers

(The median citation count of Health Economics Policy and Law is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis	23
HEP volume 17 issue 4 Cover and Back matter	23
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group	21
Priority setting for health equality – searching for an ethical framework	15
The contaminated blood scandal in England: exploring the social harms experienced by infected and affected individuals	15
From speculative to real: community attitudes towards government COVID-19 vaccine mandates in Western Australia from May 2021 to April 2022	12
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges	12
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?	11
Out with the old…	10
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-19	10
The relationship between healthcare provider ownership and performance in high-income countries: An umbrella review	9
Does elderly care suppress women’s fertility intentions? Quasi-experimental evidence from China’s home and community-based services reform	9
Saving children's lives through interventions: a quasi-experimental analysis of GAVI	8
Judicial claims for access to treatment in the private health insurance sector in Brazil	8
Politics in all policies: how healthcare is shaped by political (in)action	8
Managed competition in Colombia: convergence of public and private insurance and delivery	8
Making care primary: a renewed investment into primary care	7
A review of heath economic evaluation practice in the Netherlands: are we moving forward?	7
An examination of health care efficiency in Canada: a two-stage semi-parametric approach	6
Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public–private mix?	6
A European vision for telemedicine in cancer care: policy and patient perspectives from the eCAN Joint Action	6
Fair processes for financing universal health coverage?	6
Exploring differences between public and private providers in primary care: findings from a large Swedish region	5
Healthcare reform in the Netherlands: after 15 years of regulated competition	5
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance system	5

The state of American health coverage: the 2022 elections and the Affordable Care Act	5
Neighborhood inequalities and the decline of infant mortality in São Paulo	5
Political determinants of health: (re) examining the role of governance in reducing maternal mortality	4
The roads to managed competition for mixed public–private health systems: a conceptual framework	4
Primary care as determinant of COVID-19 and influenza vaccine uptake	4
Navigating conflicting expectations in addressing healthcare scarcity: a q-methodology study on the Dutch National Health Care Institute	4
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework	4
Medical marijuana laws and mental health in the United States	4
Market distortions in the Dutch mixed long-term care market: an exploratory analysis	4
Why do health crises matter for populism?	3
Successfully changing the mode of regulation in clinical priority setting: how organisational factors contributed to establishing the Norwegian priority guidelines for specialist health care services	3
Early child health in Africa: do ICT and democracy matter?	3
Health misinformation and freedom of expression: considerations for policymakers	3
Has regional decentralisation saved lives during the COVID-19 pandemic?	3
Acting reactively: private investment, controversies and regulatory and policy responses in residential long-term care in Ontario (Canada), Lombardy (Italy), the Netherlands and England (United Kingdo	3
Preparing for uncertainty and health system responses: a new year for Health Economics, Policy and Law	3
Response to critics of Open and Inclusive: Fair Processes for Financing Universal Health Coverage	3
Why procedural fairness is essential to financing universal health coverage	3
Do consumers perceive and trust health insurers within a system of managed competition as prudent buyers of care?	3
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era	3
An opportunity to remove harmful intellectual property provisions from the Comprehensive and Progressive Agreement for Trans-Pacific Partnership	3
Private equity involvement in primary care: the case of Ireland	3
… and in with the new	3
Regulated markets and rationalised myths: an institutional perspective on value-based purchasing in the Netherlands	2
The mixed legacy of managed competition: between policy and practice	2
Reforming the funding of long-term care for older people: costs and distributional impacts of planned changes in England	2
Depoliticising resilience? Uncovering the political theories of health system resilience	2
Pandemic preparedness and response: a new mechanism for expanding access to essential countermeasures	2
Private equity involvement in long-term care: what can we learn from the United States, Ireland, and Poland?	2
Integrated care in a Beveridge system: experiences from England and Denmark	2
Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?	1
Improving access to healthcare in Ireland: an implementation failure	1
The still incomplete pursuit of universal access to medicines	1
Managed competition in the United States: How well is it promoting equity and efficiency?	1
Coping with COVID-19: the role of hospital care structures and capacity expansion in five countries	1
How reforms hamper priority-setting in health care: an interview study with local decision-makers in London	1
‘Nurses are seen as general cargo, not the smart TVs you ship carefully’: the politics of nurse staffing in England, Spain, Sweden, and the Netherlands	1
If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands	1
A systematic literature review of real-world evidence (RWE) on post-market assessment of medical devices	1
Roadmaps to managed competition: to what extent does South Africa meet the preconditions for equity and efficiency?	1
How should medicines reimbursement work? The views of Spanish experts	1
Managed competition in Aotearoa New Zealand: past experiences and future prospects	1
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit	1
Incremental choices, system-wide impact on health system performance	1
Health system sustainability and resilience: a preliminary provision of measurement through a “mash-up” index	1
Policy shift toward mandatory premarital screening in a Middle Eastern country: agenda- setting through the lens of Kingdon’s multiple streams framework	1